Oral absorption of the HIV protease inhibitors: a current update
- 20 September 1999
- journal article
- Published by Elsevier in Advanced Drug Delivery Reviews
- Vol. 39 (1-3), 211-238
- https://doi.org/10.1016/s0169-409x(99)00027-7
Abstract
No abstract availableKeywords
This publication has 69 references indexed in Scilit:
- Antiretroviral Therapy for HIV Infection in 1998JAMA, 1998
- HIV-Protease InhibitorsNew England Journal of Medicine, 1998
- Protease inhibitors for the treatment of human immunodeficiency virus infectionAmerican Journal of Health-System Pharmacy, 1998
- Chemotherapeutic agents for human immunodeficiency virus infection: mechanism of action, pharmacokinetics, metabolism, and adverse reactionsClinical Therapeutics, 1998
- Saquinavir Soft-Gel Capsule FormulationDrugs, 1998
- Antiretroviral Therapy for HIV InfectionDrugs, 1998
- Human immunodeficiency virus protease inhibitors From drug design to clinical studiesAdvanced Drug Delivery Reviews, 1997
- Preformulation Studies of a Novel HIV Protease Inhibitor, AG1343Journal of Pharmaceutical Sciences, 1995
- Crystal structure of HIV-1 protease in complex with VX-478, a potent and orally bioavailable inhibitor of the enzymeJournal of the American Chemical Society, 1995
- The specificity of the HIV-1 proteasePerspectives in Drug Discovery and Design, 1993